Skip to Main Content

Browse issues

The Journal of Infectious Diseases Cover Image for Volume 218, Issue 1
Volume 218, Issue 1
1 July 2018
ISSN 0022-1899
EISSN 1537-6613

Volume 218, Issue 1, 1 July 2018

EDITORIAL COMMENTARIES

Lynne M Mofenson
The Journal of Infectious Diseases, Volume 218, Issue 1, 1 July 2018, Pages 1–4, https://doi.org/10.1093/infdis/jiy118
Fiona Angrisano and Andrew M Blagborough
The Journal of Infectious Diseases, Volume 218, Issue 1, 1 July 2018, Pages 5–6, https://doi.org/10.1093/infdis/jiy171

REVIEW ARTICLE

Jessica E Manning and others
The Journal of Infectious Diseases, Volume 218, Issue 1, 1 July 2018, Pages 7–15, https://doi.org/10.1093/infdis/jiy179

Mosquito saliva facilitates arboviral infection by taking advantage of the host’s innate and adaptive immune responses to saliva. This provides a rationale for creating “universal” vaccines against mosquito salivary proteins, rather than against the viruses contained within the saliva.

MAJOR ARTICLES AND BRIEF REPORTS

HIV/AIDS

Kerry A Thomson and others
The Journal of Infectious Diseases, Volume 218, Issue 1, 1 July 2018, Pages 16–25, https://doi.org/10.1093/infdis/jiy113

The risk of human immunodeficiency virus type 1 (HIV-1) acquisition by women per condomless sex act was 3-fold and 4-fold higher during late pregnancy and the postpartum period, respectively, relative to the nonpregnant period. Enhanced HIV-1 prevention and testing strategies are needed during pregnancy and the postpartum period.

Paraskevi F Farmaki and others
The Journal of Infectious Diseases, Volume 218, Issue 1, 1 July 2018, Pages 26–34, https://doi.org/10.1093/infdis/jiy135

In adults with treated human immunodeficiency virus infection, receipt of 23-valent pneumococcal polysaccharide vaccine 12 months after receipt of 13-valent pneumococcal conjugate vaccine (PCV13) enhanced PCV13 immunogenicity but reduced the number of PCV13-induced polysaccharide-specific immunoglobulin M–expressing memory B cells.

PATHOGENESIS AND HOST RESPONSE

Gaoqian Feng and others
The Journal of Infectious Diseases, Volume 218, Issue 1, 1 July 2018, Pages 35–43, https://doi.org/10.1093/infdis/jiy170

Human immunization with a polymorphic malaria vaccine candidate, MSP2, induced functional cross-reactive antibodies targeting conserved epitopes. This contrasts with naturally acquired antibodies, which target polymorphic epitopes, mediating immune escape. Findings reveal potential to overcome antigenic diversity for effective malaria vaccines.

Anshu Babbar and others
The Journal of Infectious Diseases, Volume 218, Issue 1, 1 July 2018, Pages 44–52, https://doi.org/10.1093/infdis/jiy110

This study highlights the relevance of preexisting pathogen-specific antibodies for restricting rapidly spreading necrotizing soft-tissue infections caused by Streptococcus pyogenes, as well as the potential beneficial effect of intravenous immunoglobulin–based therapy for ameliorating the severity of these devastating infections.

Michael E Urbanowski and others
The Journal of Infectious Diseases, Volume 218, Issue 1, 1 July 2018, Pages 53–63, https://doi.org/10.1093/infdis/jiy127

Repetitive aerosol exposure in the rabbit tuberculosis model generated a greater number of cavities and increased lung damage than when the same inoculum was given once. The model was used to test an anti–MMP-1 drug, cipemastat, as a host-directed therapy.

Chao Liu and others
The Journal of Infectious Diseases, Volume 218, Issue 1, 1 July 2018, Pages 64–74, https://doi.org/10.1093/infdis/jiy149
Inés Sananez and others
The Journal of Infectious Diseases, Volume 218, Issue 1, 1 July 2018, Pages 75–83, https://doi.org/10.1093/infdis/jiy180

A reduced ability to produce IL-2 and a limited response to this cytokine may affect the function of CD4+ T cells in RSV-infected infants.

VIRUSES

Mahboobeh Safaeian and others
The Journal of Infectious Diseases, Volume 218, Issue 1, 1 July 2018, Pages 84–94, https://doi.org/10.1093/infdis/jiy112

Using data from PATRICIA and Costa Rica Vaccine trials, the risk of detecting a new HPV-18 infection and associated lesions was compared between women HPV seropositive and seronegative at enrollment. High HPV-18 naturally acquired antibodies were associated with partial protection.

S M Garland and others
The Journal of Infectious Diseases, Volume 218, Issue 1, 1 July 2018, Pages 95–108, https://doi.org/10.1093/infdis/jiy133

The 9vHPV vaccine was efficacious, immunogenic, and well-tolerated in Asian participants from 2 international, randomized clinical trials. Data support 9vHPV vaccination programs in Asia.

Eshan U Patel and others
The Journal of Infectious Diseases, Volume 218, Issue 1, 1 July 2018, Pages 109–113, https://doi.org/10.1093/infdis/jiy165

Temporal trends in human papillomavirus vaccine coverage were assessed among 2011–2016 National Health and Nutrition Examination Surveys participants aged 9–26 years. Coverage substantially increased among males, but minimal gains were observed among females. Coverage remains below national targets.

Kai-Henrik Peiffer and others
The Journal of Infectious Diseases, Volume 218, Issue 1, 1 July 2018, Pages 114–123, https://doi.org/10.1093/infdis/jiy119

PreS mutations, detected in released viral genomes, did not affect HBsAg expression in HBeAg-negative chronic HBV-infected patients. In these patients, HBsAg is presumably derived from the integrated DNA. This HBsAg source should be considered for novel antiviral strategies.

Jessica C Joyce and others
The Journal of Infectious Diseases, Volume 218, Issue 1, 1 July 2018, Pages 124–132, https://doi.org/10.1093/infdis/jiy139

Microneedle (MN) patches containing measles and rubella (MR) vaccine induced comparable immune responses to subcutaneous injection in infant rhesus macaques and protected them from measles challenge. Use of MN patch vaccines could help to increase MR vaccination coverage rates.

Yuanyun Ao and others
The Journal of Infectious Diseases, Volume 218, Issue 1, 1 July 2018, Pages 133–143, https://doi.org/10.1093/infdis/jiy182

This study provides the strong evidence in tracing the evolutionary origin and elucidating its evolutionary dynamics of the reemerging GII.P16/GII.2 noroviruses, and illustrates the mechanism behind its predominance.

Florence Buseyne and others
The Journal of Infectious Diseases, Volume 218, Issue 1, 1 July 2018, Pages 144–151, https://doi.org/10.1093/infdis/jiy181

Zoonotic simian foamy virus (SFV) establishes persistent infections in humans. A case-control study of Cameroonian hunters showed the absence of clinical signs and the presence of hematological abnormalities in SFV-infected humans, half of whom had mild or moderate anemia.

PARASITES

Maxine McKenzie and others
The Journal of Infectious Diseases, Volume 218, Issue 1, 1 July 2018, Pages 152–164, https://doi.org/10.1093/infdis/jix654

Functional analysis of activated Akt/protein kinase B in Schistosoma mansoni revealed that Akt regulates the expression and evolution of the glucose transporter SGTP4 at the parasite surface and concomitant glucose uptake in schistosomules and adult worms.

BACTERIA

Ekta Lachmandas and others
The Journal of Infectious Diseases, Volume 218, Issue 1, 1 July 2018, Pages 165–170, https://doi.org/10.1093/infdis/jiy173

Our study reveals that human tissue challenged with mycobacterial antigens induces differential expression of genes that regulate multiple metabolic pathways. We demonstrate that variable expression of these metabolic genes influences the cytokine response of immune cells stimulated by Mycobacterium tuberculosis.

ERRATA

The Journal of Infectious Diseases, Volume 218, Issue 1, 1 July 2018, Page 171, https://doi.org/10.1093/infdis/jiy195
The Journal of Infectious Diseases, Volume 218, Issue 1, 1 July 2018, Page 171, https://doi.org/10.1093/infdis/jiy226
The Journal of Infectious Diseases, Volume 218, Issue 1, 1 July 2018, Pages 171–172, https://doi.org/10.1093/infdis/jiy254
Close
This Feature Is Available To Subscribers Only

Sign In or Create an Account

Close

This PDF is available to Subscribers Only

View Article Abstract & Purchase Options

For full access to this pdf, sign in to an existing account, or purchase an annual subscription.

Close